Liquidia Corporation (LQDA)
NASDAQ·Healthcare·Medical - Pharmaceuticals
$67.27
-0.91%
Mkt Cap $6.11B
Analyst Ratings
No recent rating data.
Price Target (23 analysts)
$74.83
Range $60.00 – $109.00
Implied Upside
+11.2%
Consensus $74.83 vs current $67.27